Fosun Orinove Pharmatech, Inc.

China

 
Total IP 16
Total IP Rank # 94,274
IP Activity Score 1.4/5.0    5
IP Activity Rank # 195,412

Patents

Trademarks

8 0
4 0
4 0
0
 
Last Patent 2023 - Method for preparing coumarin co...
First Patent 2005 - Ire-1α substrates

Latest Inventions, Goods, Services

2020 Invention Method for preparing coumarin compounds substituted by amidoalkyl at 3-position, the products and...
Invention A method for preparing coumarin compounds substituted by amidoalkyl at 3-position, the products a...
Invention Method for preparing coumarin compound, 3 position of which is substituted with amidoalkyl and pr...
2019 Invention Ire1a inhibitor in combination with cancer therapeutic agent for cancer treatment. Provided are ...
Invention Ire1a inhibitor in combination with cancer therapeutic agent for cancer treatment. Provided are a...
Invention Ire-1α inhibitors. Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharm...
2018 Invention Ire1α inhibitor in combination with cancer therapeutic agent for cancer treatment. Provided are a...
2016 Invention Ire-1alpha inhibitors. The invention provides compounds which directly inhibit IRE-1α activity in...
2011 Invention Ire-1α substrates. IRE-1α substrates useful for identifying agonists and antagonists of IRE-1α RN...
Invention Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE-1 ot activity in vitro, prodrugs, a...
2010 Invention Ire-1α inhibitors. The invention provides compounds which directly inhibit IRE-1α activity in vit...
Invention Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE-1.alpha. activity in vitro, prodrug...
Invention Ire-1.alpha. inhibitors. The invention provides compounds which directly inhibit IRE-1a activity ...
2008 Invention Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE- 1.alpha. activity in vitro, prodru...
Invention Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE-la activity in vitro, prodrugs, and...